1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
- 2014
-
Mark
Human IgE against the major allergen Bet v 1 - defining an epitope with limited cross-reactivity between different PR-10 family proteins.
(
- Contribution to journal › Article
-
Mark
Genetically
restricted
local IgE
repertoires
from
nasal
tssue
of
allergic donors
target
multiple
epitopes
on
Bet
v
1
2014) European Academy of Allergy and Clinical Immunology Congress 2014(
- Contribution to conference › Abstract